Publications, Pharmaceutical

Aptar Pharma Q&A on trends and challenges in nasal drug delivery

Nasal drug delivery is currently the focus of considerable drug development activity.

This Q&A takes a detailed look at the nasal drug delivery landscape and the potential of this route for the delivery of vaccines and therapeutics for COVID-19, for nose-to-brain drug delivery and for improving the accessibility of emergency medications. Key challenges associated with the development of nasal drug products are outlined along with factors impacting device design and selection.
The regulatory landscape is also considered. Barriers to the development of nasal drug delivery products are examined but it is concluded that the route has a bright future with considerable potential to address currently unmet therapeutic needs.

Download the Q&A
Author(s): Dr Julie D. Suman
21 Apr 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More

This Might Also Be of Interest

1 Sep 2022

Development of In Vitro Nasal Cast Imaging Techniques to Predict In Vivo Nasal Deposi...

Publications, Pharmaceutical, Device Innovations, Product Solutions

Read More
1 Sep 2022

Investigation of Powder Blend Uniformity and Deposition in a Nasal Cast Using a Unit ...

Publications, Pharmaceutical, Device Innovations, Product Solutions

Read More
1 Sep 2022

In Vitro and In Vivo Assessment of Regional Nasal Deposition using Scintigraphy from ...

Publications, Pharmaceutical, Device Innovations, Product Solutions

Read More
12 Jul 2022

Nasal Drug Delivery: Beyond Hayfever

Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Read More
1 … 9 10 11 12 13 … 25

Request Access

Close

Requesting access to Aptar Pharma Q&A on trends and challenges in nasal drug delivery.

  • This field is for validation purposes and should be left unchanged.

How Can We Help?

Back To Top